S B Olsson. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Action Potentials/drug effectsAdministration, OralAdolescentAdrenergic beta-Antagonists/pharmacologyAnti-Arrhythmia Agents/administration & dosageAnti-Arrhythmia Agents/pharmacologyAnti-Arrhythmia Agents/therapeutic useArrhythmias, Cardiac/drug therapyAtrial FunctionHumansInjections, IntravenousMalePropranolol/administration & dosagePropranolol/pharmacologyPropranolol/therapeutic useReceptors, Adrenergic/drug effects
Substances: See more » Adrenergic beta-AntagonistsAnti-Arrhythmia AgentsReceptors, AdrenergicPropranolol
Year: 1971 PMID: 4402873 DOI: 10.1007/bf00568891
Source DB: PubMed Journal: Eur J Clin Pharmacol ISSN: 0031-6970 Impact factor: 2.953